Cited by 210Genetic Neurodegenerative DiseasesPrion Diseases and Protein MisfoldingLysosomal Storage Disorders Research

Transfer of polyglutamine aggregates in neuronal cells occurs in tunneling nanotubes

Open access
Costanzo, Maddalena, Abounit, Saïda, Marzo, Ludovica, Danckaert, Anne, Chamoun, Zeina, Roux, Pascal, Zurzolo, Chiara·2013·Journal of Cell Science

Abstract

Huntington's disease (HD) is a dominantly inherited neurodegenerative disease caused by CAG expansion in the huntingtin gene, which adds a homopolymeric tract of polyglutamine (polyQ) to the encoded protein leading to the formation of toxic aggregates. Despite rapidly accumulating evidences supporting a role for intercellular transmission of protein aggregates, little is known about whether and how huntingtin (Htt) misfolding progresses through the brain. It has been recently reported that synthetic polyQ peptides and recombinant fragments of mutant Htt are readily internalized in cell cultures and able to seed polymerization of a reporter wild-type Htt. However, there is no direct evidence of aggregate transfer between cells and the mechanism has not been explored. By expressing recombinant fragments of mutant Htt in neuronal cells and in primary neurons, we found that aggregated fragments formed within one cell spontaneously transfer to neighbors in cell culture. We demonstrate that the intercellular spreading of the aggregates requires cell-cell contact and does not occur upon aggregate secretion. Interestingly, we found that the expression of mutant, but not wild-type Htt fragments, increases the number of tunneling nanotubes, which in turn provide an efficient mechanism of transfer.

Integrity signals

Registry

Crossref · 10.1242/jcs.126086

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In Huntington's disease, actin remodeling promotes tunneling nanotube formation, with Rhes-driven tunnels and TNTs facilitating intercellular transfer of mutant huntingtin and polyglutamine aggregates.

    “In HD, actin remodeling promotes TNT formation, with Rhes-driven “Rhes tunnels” and TNTs facilitating intercellular transfer of mutant huntingtin and polyglutamine aggregates, potentially complementing EV-mediated export observed in patient biofluids (Figure 3C) [186,187,188].”
  • Mutant HTT propagates between neurons via tunneling nanotubes and extracellular vesicles, including exosomes carrying misfolded protein cargo.

    “In addition to disrupted intracellular transport, accumulating evidence suggests that mutant HTT propagates between neurons via TNTs and EVs, including exosomes carrying misfolded protein cargo [186,187,196].”
  • This TNT-mediated transfer potentially complements EV-mediated export observed in Huntington's disease patient biofluids.

    “In HD, actin remodeling promotes TNT formation, with Rhes-driven “Rhes tunnels” and TNTs facilitating intercellular transfer of mutant huntingtin and polyglutamine aggregates, potentially complementing EV-mediated export observed in patient biofluids (Figure 3C) [186,187,188].”

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 42 · Cited by 210

Authors
Costanzo, M., Abounit, S., Marzo, L., Danckaert, A., Chamoun, Z., Roux, P., & Zurzolo, C.
Affiliations
Institut Pasteur (FR)
Corresponding author
Zurzolo, Chiara
Venue
Journal of Cell Science
Published
2013-01-01
Volume
126
Issue
Pt 16
Pages
3678-85
ISSN
  • 0021-9533 (ISSN-L)
  • 1477-9137
OpenAlex
W2091458985
Cited by
210
References
42
Citations by year
2026: 5 · 2025: 8 · 2024: 14 · 2023: 13 · 2022: 24 · 2021: 23 · 2020: 14 · 2019: 11 · 2018: 18 · 2017: 31 · 2016: 18 · 2015: 17 · 2014: 9 · 2013: 4
FWCI
7.84
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Journal of Cell Science (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
Funders
Agence Nationale de la Recherche (ANR-09-NEUR-0002, ANR-09-BLAN-0122)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
  • Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
Keywords
Huntington's disease, polyglutamine aggregates, huntingtin, tunneling nanotubes, cell-cell contact, neurons, CAG repeat expansion, protein misfolding, neurodegeneration
MeSH terms
Amino Acid Sequence, Animals, Humans, Huntington Disease, Neurons, Peptides, Transfection, Nanotubes, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review